Singapore, April 2 -- Peijia Medical Technology (Suzhou) Co. recently held a strategic innovation cooperation signing ceremony and a press conference to announce the research and development achievements of polymer heart valves using ultra-high molecular weight polyethylene (UHMWPE) and thermoplastic polyurethane (TPU) from the Biomedical business of dsm-firmenich, innovators in nutrition, health, and beauty, at Peijia Medical's global headquarters.
The signing of the strategic innovation partnership agreement between the two parties will further focus on the research and development innovation of polymer heart valve materials, which is expected to initiate an epoch-making transformation in the field of high-end medical device materials ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.